Search Results
Updates in treatments for HER2-positive GEA
Advances in treatments for HER2-positive metastatic breast cancer
Protocols for HER2-Expressing GI Cancers: Refining BTC and GEA Care With Targeted Agents
HER2-Positive Gastrointestinal Cancers: New Evidence and Practical Guidance With Targeted Agents
Practice-Changing Updates in the First-Line Treatment of Gastric/GEJ Cancer (1 of 2)
32 First Line Therapy for HER2+ GEA
Zanidatamab + chemo as 1L therapy in HER2-expressing GEA
Updates from the MAHOGANY study in gastric cancer
Recent therapies for HER2 advanced breast cancer
38 Second Line & Later Therapy for HER2+
Zanidatamab and chemotherapy in HER2+ gastroesophageal cancer
Dr. Crew on Updated Data With Margetuximab in HER2+ Breast Cancer